arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Connect Biopharma Holdings Limited

CNTB Health Care Biotechnology: Pharmaceutical Preparations
$2.18
Today
as of Aug 5, 16:47 ET
Last 30 days -8.40% Jun 29 → Aug 05
$1.91 $2.11 $2.32 $2.52 $2.72 Jun 29 Jul 07 Jul 14 Jul 22 Jul 29 Aug 05
Open
$2.31
High
$2.43
Low
$2.13
Volume
$277,450
Avg Vol
$208,577
Mkt Cap
$124M
P/E (TTM)
—
Beta
—
52w High
$3.82
52w Low
$0.75
Div Yield
—
Shares Out
$63M

Recent Press Releases & News last 60 days · 2 items

Jul 9 · 12:30 MT Newswires
Oppenheimer Initiates Connect Biopharma at Outperform With $8 Price Target
Jun 17 · 13:00 PR GlobeNewswire
Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma

Overview

52-week range
$0.75
$3.82
47% of range
Avg surprise (last 3)
+1.7%
Avg reaction (last 2)
+4.5%
50% positive
Latest IV / EM
122%
EM ±20.4% · $3 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.34$-0.19$-0.03$0.12$0.27 Actual $-0.16Actual $0.27Actual $-0.23Actual $-0.19Est $-0.26Actual $-0.23Est $-0.22Actual $-0.31Actual $-0.34Est $-0.29 MarJunSepMar/2025Jun/2025SepMar/2026
Revenue vs Net Income Revenue Net income
$-19M$-8M$3M$14M$25M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.34 $-0.29 -17.2% -79.0% +14.5% earnings
Tue Sep 30, 2025Sep 2025 $-0.31 — — — — financials
Wed Aug 13, 2025Jun/2025 $-0.23 $-0.22 -4.5% — — earnings
Thu May 15, 2025Mar/2025 $-0.19 $-0.26 +26.9% — -5.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.23 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.27 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.16 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Aug 12, 2026Jun/2026OTHER -$0.32-$0.23 -39.1%

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$169,000—$16,000$48,000$0—$1M$24M
Cost of revenue————————
Gross profit————————
Operating income$-20M—$-18M$-13M$-11M—$-14M$14M
Net income$-19M—$-17M$-13M$-10M—$-13M$15M
EPS (diluted)$-0.34—$-0.31$-0.23$-0.19—$-0.23$0.27

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$46M$38M$38M$41M$48M$78M——
Inventory————————
Total current assets$55M$51M$63M$78M$88M$97M——
Total assets$60M$56M$67M$83M$93M$101M——
Long-term debt————————
Total liabilities$17M$14M$12M$11M$10M$9M——
Total equity$43M$42M$55M$71M$83M$92M$101M$111M

Implied volatility — last 90 days

121%379%636%893%1151% Jun 07 — IV 200% · EM ±27.6%Jun 08 — IV 207% · EM ±27.3%Jun 09 — IV 226% · EM ±28.3%Jun 10 — IV 265% · EM ±31.2%Jun 11 — IV 302% · EM ±33.3%Jun 12 — IV 300% · EM ±30.7%Jun 15 — IV 503% · EM ±36.4%Jun 16 — IV 723% · EM ±42.7%Jun 17 — IV 1151% · EM ±48.1%Jul 01 — IV 144% · EM ±24.1%Jul 02 — IV 151% · EM ±24.4%Jul 07 — IV 205% · EM ±27.0%Jul 08 — IV 216% · EM ±27.0%Jul 10 — IV 126% · EM ±13.9%Jul 13 — IV 282% · EM ±23.6%Jul 14 — IV 205% · EM ±14.9%Jul 15 — IV 279% · EM ±16.5%Jul 16 — IV 461% · EM ±19.3%Jul 20 — IV 180% · EM ±42.6%Jul 21 — IV 185% · EM ±43.0%Jul 22 — IV 189% · EM ±43.2%Jul 23 — IV 192% · EM ±43.2%Jul 24 — IV 222% · EM ±49.1%Jul 27 — IV 239% · EM ±50.0%Jul 29 — IV 158% · EM ±31.7%Jul 30 — IV 134% · EM ±26.3%Aug 03 — IV 129% · EM ±22.8%Aug 04 — IV 126% · EM ±21.7%Aug 05 — IV 122% · EM ±20.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in